← Back to Search

Joint Replacement

Hip Resurfacing for Arthritis (BHR Trial)

N/A
Waitlist Available
Led By Christopher Drinkwater, MD
Research Sponsored by Smith & Nephew, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 21 years of age and skeletally mature
Patients requiring primary hip resurfacing due to non-inflammatory arthritis such as osteoarthritis, traumatic arthritis, avascular necrosis, or dysplasia/DDH
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post op through 10 years
Awards & highlights

BHR Trial Summary

This trial will evaluate the long-term safety and effectiveness of the BHR system in patients with arthritis.

Who is the study for?
This trial is for adults over 21 with arthritis needing hip resurfacing, who can follow up for ten years. It's not for those with infections, severe muscle or nerve diseases, poor bone quality, metal allergies, women of childbearing age, the immunosuppressed or severely overweight individuals.Check my eligibility
What is being tested?
The study tests the long-term safety and effectiveness of the Birmingham Hip Resurfacing (BHR) System in patients with various types of arthritis including osteoarthritis and rheumatoid arthritis.See study design
What are the potential side effects?
While specific side effects are not listed here, typical risks may include pain at the surgery site, infection risk from surgery, possible reaction to materials used in BHR system if there's a metal sensitivity.

BHR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 or older and my bones have stopped growing.
Select...
I need hip resurfacing due to arthritis or hip damage not caused by inflammation.
Select...
I need hip surgery due to arthritis like rheumatoid arthritis.

BHR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post op through 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and post op through 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness evaluation based on incidence of revision, radiographic review and Harris Hip Score
Secondary outcome measures
Adverse events

BHR Trial Design

1Treatment groups
Experimental Treatment
Group I: Hip ResurfacingExperimental Treatment1 Intervention
Birmingham Hip Resurfacing

Find a Location

Who is running the clinical trial?

Smith & Nephew, Inc.Lead Sponsor
165 Previous Clinical Trials
22,121 Total Patients Enrolled
15 Trials studying Arthritis
1,675 Patients Enrolled for Arthritis
Christopher Drinkwater, MDPrincipal InvestigatorUniversity of Rochester
Edwin Su, MDPrincipal InvestigatorHospital for Special Surgery, New York
1 Previous Clinical Trials
200 Total Patients Enrolled

Media Library

Birmingham Hip Resurfacing System (Joint Replacement) Clinical Trial Eligibility Overview. Trial Name: NCT00611585 — N/A
Arthritis Research Study Groups: Hip Resurfacing
Arthritis Clinical Trial 2023: Birmingham Hip Resurfacing System Highlights & Side Effects. Trial Name: NCT00611585 — N/A
Birmingham Hip Resurfacing System (Joint Replacement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00611585 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are seniors eligible for this clinical exploration?

"As per the regulations of this clinical trial, eligible participants must be between 21 and 75 years old."

Answered by AI

Who meets the criteria to partake in this experiment?

"The trial is open to those aged 21-75 years old who suffer from either non-inflammatory (e.g., osteoarthritis, traumatic arthritis, avascular necrosis, or dysplasia/DDH) or inflammatory (e.g., rheumatoid arthritis) forms of arthritis and fulfil the following requirements: at least 21 years of age and skeletally mature; willing to sign an approved consent form; available for clinical follow up for ten years; none of the exclusion criteria present."

Answered by AI

How many healthcare facilities are conducting this research project?

"The current list of recruiting sites includes the Center for Orthopaedics in Lake Charles, Louisiana, Aurora Medical Centre in Grafton, Wisconsin and University of Rochester Medical Centre located in Rochester, New york. There are also 7 additional locations accepting patients into this clinical trial."

Answered by AI

Is there presently an opportunity for individuals to join this research?

"Data from clinicaltrials.gov suggests that this trial is not recruiting participants at the present time, even though it was initially posted in September 2006 and updated as recently as November 2022. Despite its non-active status, there are 365 other trials which have open recruitment positions right now."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
2006. "A Safety and Efficacy Study of the Birmingham Hip Resurfacing System". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00611585.
All > Arthritis
~46 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top